Abstract: Methods for the manufacture of polysaccharide-protein conjugate vaccines at high yield are provided. The methods involve reaction of a hydrazide group on one reactant with an aldehyde group on the other reactant. The reaction proceeds rapidly with a high conjugation efficiency. Simplified purification processes can be employed to separate the conjugate product from the unconjugated protein and polysaccharide and other small molecule by-products.
Type:
Grant
Filed:
August 6, 2004
Date of Patent:
November 3, 2015
Assignees:
The United States of America, as represented by the Secretary, Department of Health and Human Services, Fiocruz
Inventors:
Ellen Jessouroun, Ivna Alana Freitas Brasileiro Da Silveira, Renata Chagas Bastos, Carl E. Frasch, Che-Hung Robert Lee